Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-04-23

Clinical Trial Update: Supraphysiologic Insulin to Improve Outcomes After Surgical Treatment of Unruptured Cerebral Aneurysms [NA]

View source ↗

Summary

This clinical trial evaluated supraphysiologic insulin to improve outcomes after surgical treatment of unruptured intracranial aneurysms. The study has been wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Northwestern University | Conditions: Intracranial Aneurysm | NA | Status: WITHDRAWN